Alpha Tau and MIM Software Announce Collaboration for Alpha DaRT Treatment Planning
August 22, 2022 09:00 ET
|
Alpha Tau Medical Ltd.
JERUSALEM and CLEVELAND, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Today, Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and...
Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials
July 05, 2022 16:01 ET
|
Alpha Tau Medical Ltd.
JERUSALEM, July 05, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau" or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,...
Alpha Tau Medical Initiates First Clinical Trial in Italy to Treat Cancer with Alpha Radiation
October 30, 2017 07:30 ET
|
Alpha Tau Medical LTD.
TEL AVIV, Israel, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Alpha Tau Medical is happy to announce its first clinical trial in Italy. The study at IRST, Meldola, will evaluate the feasibility, safety and...
Alpha Tau Medical avvia la prima sperimentazione clinica in Italia per la cura del tumore con le radiazioni alfa
October 30, 2017 04:40 ET
|
Alpha Tau Medical LTD.
TEL AVIV, Israele, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Alpha Tau Medical è lieta di annunciare l’avvio della sua prima sperimentazione clinica in Italia. Lo studio che sarà condotto presso l’IRST, a...